A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are higher this morning, ahead of earnings reports from major companies. Futures for the Dow Jones Industrial Average surged 70 points to 12,672.00 and S&P 500 index futures rose 7.30 points to 1,316.20. Nasdaq 100 futures gained 14.50 points to 2,476.50.
A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index surged 0.92%, London's FTSE 100 Index moved up 0.65%, French CAC 40 index rose 1.40% and German DAX 30 index gained 0.98%.
Asian markets ended mostly higher, with Japan's Nikkei Stock Average rising 0.1076%, China's Shanghai Composite gaining 0.33% and Australia's S&P/ASX 200 moving down 0.20%. Hong Kong's Hang Seng index rose 1.1413% and India's Sensex jumped 1.96%.
Broker Recommendation Analysts at Credit Suisse upgraded Aon Corporation (NYSE: AON) from “underperform” to “neutral.” The target price for Aon has been raised from $44 to $50.
Aon shares dropped 0.04% to close at $47.97 yesterday.
Breaking news
- Hi-Tech Pharmacal Co Inc (NASDAQ: HITK) announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated New Drug Application,for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne's Lorazepam Intensol® oral concentrate which had combined brand and generic sales of $10 million for the 12 months ended December 2011 according to IMS sales data. To read the full news, click here.
- Mattel Inc (NASDAQ: MAT) reported a rise in its fourth-quarter net income. To read the full news, click here.
- Foster Wheeler AG (NASDAQ: FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a project management consultancy contract by 2Co Power (Yorkshire) Limited (2Co) for the Don Valley Power Project in Stainforth, Yorkshire, UK. To read the full news, click here.
- Spectrum Pharmaceuticals (NASDAQ: SPPI) announced that it has entered into a co-development and commercialization agreement with Hanmi Pharmaceutical Company for SPI-2012, a drug for the treatment of chemotherapy induced neutropenia based on Hanmi's proprietary LAPSCOVERY™ Technology. To read the full news, click here.
